In pancreatic cancer, CXCR4 methylation occurred in 46% of the tumors but did not display any significant associations with common clinicopathological factors, such as age, gender, stage or lymph node metastasis [18]. The gene discussed is CXCR4; the disease is metastatic malignant neoplasm in the lymph nodes.